Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2020-03-26 4:39 pm Purchase | 13G | CATALYST PHARMACEUTICALS INC. CPRX | ARMISTICE CAPITAL LLC | 5,378,000 5.2% | 5,378,000 (New Position) | View |
| 2020-02-14 10:12 am Purchase | 13G | CATALYST PHARMACEUTICALS INC. CPRX | STATE STREET CORP STT | 7,418,295 7.2% | 7,418,295 (New Position) | View |
| 2020-02-13 5:19 pm Unchanged | 13G | CATALYST PHARMACEUTICALS INC. CPRX | Broadfin Capital LLC | 0 0% | 0 (Unchanged) | View |
| 2020-02-13 5:12 pm Sale | 13G | CATALYST PHARMACEUTICALS INC. CPRX | Broadfin Capital LLC | 0 0% | -6,268,298 (Position Closed) | View |
| 2020-02-05 11:25 am Purchase | 13G | CATALYST PHARMACEUTICALS INC. CPRX | BlackRock Inc. BLK | 8,444,965 8.2% | 1,474,092 (+21.15%) | View |
| 2020-01-09 4:59 pm Sale | 13G | CATALYST PHARMACEUTICALS INC. CPRX | Consonance Capital Management LP | 0 0% | -5,171,464 (Position Closed) | View |
| 2019-12-09 4:37 pm Sale | 13G | CATALYST PHARMACEUTICALS INC. CPRX | Consonance Capital Management LP | 5,171,464 5.02% | -8,089,499 (-61.00%) | View |